These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis. Feng T; Cao AT; Weaver CT; Elson CO; Cong Y Gastroenterology; 2011 Jun; 140(7):2031-43. PubMed ID: 21419767 [TBL] [Abstract][Full Text] [Related]
8. Colitis induced by enteric bacterial antigen-specific CD4+ T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12. Cong Y; Weaver CT; Lazenby A; Elson CO J Immunol; 2000 Aug; 165(4):2173-82. PubMed ID: 10925304 [TBL] [Abstract][Full Text] [Related]
9. Septic mucosal intraepithelial lymphoid immune suppression: role for nitric oxide not interleukin-10 or transforming growth factor-beta. Chung CS; Song GY; Wang W; Chaudry IH; Ayala A J Trauma; 2000 May; 48(5):807-12; discussion 812-3. PubMed ID: 10823523 [TBL] [Abstract][Full Text] [Related]
10. Cholera toxin subunit B inhibits IL-12 and IFN-{gamma} production and signaling in experimental colitis and Crohn's disease. Coccia EM; Remoli ME; Di Giacinto C; Del Zotto B; Giacomini E; Monteleone G; Boirivant M Gut; 2005 Nov; 54(11):1558-64. PubMed ID: 16105891 [TBL] [Abstract][Full Text] [Related]
11. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Strober W; Kelsall B; Fuss I; Marth T; Ludviksson B; Ehrhardt R; Neurath M Immunol Today; 1997 Feb; 18(2):61-4. PubMed ID: 9057354 [TBL] [Abstract][Full Text] [Related]
12. Modulation of cytokine responses of murine CD8+ alphabeta intestinal intraepithelial lymphocytes by IL-4 and IL-12. Gelfanova V; Lai Y; Gelfanov V; Tzou S; Tu Y; Liao N J Biomed Sci; 1999; 6(4):269-76. PubMed ID: 10420084 [TBL] [Abstract][Full Text] [Related]
13. Granzyme A and CD160 expression delineates ILC1 with graded functions in the mouse liver. Di Censo C; Marotel M; Mattiola I; Müller L; Scarno G; Pietropaolo G; Peruzzi G; Laffranchi M; Mazej J; Hasim MS; Asif S; Russo E; Tomaipitinca L; Stabile H; Lee SH; Vian L; Gadina M; Gismondi A; Shih HY; Mikami Y; Capuano C; Bernardini G; Bonelli M; Sozzani S; Diefenbach A; Ardolino M; Santoni A; Sciumè G Eur J Immunol; 2021 Nov; 51(11):2568-2575. PubMed ID: 34347289 [TBL] [Abstract][Full Text] [Related]
14. Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues. Cella M; Gamini R; Sécca C; Collins PL; Zhao S; Peng V; Robinette ML; Schettini J; Zaitsev K; Gordon W; Bando JK; Yomogida K; Cortez V; Fronick C; Fulton R; Lin LL; Gilfillan S; Flavell RA; Shan L; Artyomov MN; Bowman M; Oltz EM; Jelinsky SA; Colonna M Nat Immunol; 2019 Aug; 20(8):980-991. PubMed ID: 31209406 [TBL] [Abstract][Full Text] [Related]
15. Lack of IL-7 and IL-15 signaling affects interferon-γ production by, more than survival of, small intestinal intraepithelial memory CD8+ T cells. Isakov D; Dzutsev A; Berzofsky JA; Belyakov IM Eur J Immunol; 2011 Dec; 41(12):3513-28. PubMed ID: 21928282 [TBL] [Abstract][Full Text] [Related]
16. Type 1 innate lymphoid cell aggravation of atherosclerosis is mediated through TLR4. Wu C; He S; Liu J; Wang B; Lin J; Duan Y; Gao X; Li D Scand J Immunol; 2018 May; 87(5):e12661. PubMed ID: 29570822 [TBL] [Abstract][Full Text] [Related]
17. Campylobacter infection promotes IFNγ-dependent intestinal pathology via ILC3 to ILC1 conversion. Muraoka WT; Korchagina AA; Xia Q; Shein SA; Jing X; Lai Z; Weldon KS; Wang LJ; Chen Y; Kummer LW; Mohrs M; Vivier E; Koroleva EP; Tumanov AV Mucosal Immunol; 2021 May; 14(3):703-716. PubMed ID: 33214656 [TBL] [Abstract][Full Text] [Related]
18. CCR8 Signaling Kang L; Schmalzl A; Leupold T; Gonzalez-Acera M; Atreya R; Neurath MF; Becker C; Wirtz S Front Immunol; 2020; 11():609400. PubMed ID: 33613532 [TBL] [Abstract][Full Text] [Related]
19. Involvement of interleukin 18 in Crohn's disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models. Maerten P; Shen C; Colpaert S; Liu Z; Bullens DA; van Assche G; Penninckx F; Geboes K; Vanham G; Rutgeerts P; Ceuppens JL Clin Exp Immunol; 2004 Feb; 135(2):310-7. PubMed ID: 14738461 [TBL] [Abstract][Full Text] [Related]